CFCGF yields 5.11% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, CFCGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CFCGF + JNJ for your $10,000?
Café de Coral Holdings Limited, an investment holding company, operates quick service restaurants, and casual dining chains in Hong Kong and Mainland China. The company operates restaurants primarily under the Café de Coral, Super Super Congee & Noodles, The Spaghetti House, Oliver's Super Sandwiches, Shanghai Lao Lao, Mixian Sense, Don Don Tei, THE CUP, Little Onion, and Lane Noodles brands. It also provides institutional catering services under the Asia Pacific Catering and Luncheon Star brands for universities, hospitals, government, and public and private institutions; and produces, distributes, and sells ham and sausage products under the Viking Boat brand name for supermarket chains, convenience stores, bakeries, fast food restaurants, and hotels. In addition, the company is involved in the property investment, premises space and property leasing, and food trading and processing activities. As of March 31, 2022, it had 500 operating units. The company was incorporated in 1968 and is headquartered in Sha Tin, Hong Kong.
Full CFCGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.